- cafead   May 09, 2023 at 12:02: AM
via Biotech executive Raymond Stevens, Ph.D., recalls the public biotech market of 2013, when a lot of companies were “wondering and waiting,” biding their time and assessing their value as recovery from the 2008 housing crisis dragged on. The way he remembers it, “the market had been closed.”
article source
article source